Mitsubishi UFJ Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-28,070
| Closed | -$6.9M | – | 1165 |
|
|
2022
Q3 | $6.9M | Buy |
28,070
+1,383
| +5% | +$373K | 0.02% | 487 |
|
|
2022
Q2 | $6.61M | Buy |
26,687
+1,910
| +8% | +$515K | 0.03% | 497 |
|
|
2022
Q1 | $8.21M | Buy |
24,777
+3,320
| +15% | +$1.02M | 0.03% | 472 |
|
|
2021
Q4 | $7.86M | Buy |
21,457
+1,789
| +9% | +$604K | 0.03% | 498 |
|
|
2021
Q3 | $6.4M | Buy |
19,668
+2,727
| +16% | +$924K | 0.03% | 505 |
|
|
2021
Q2 | $5.29M | Buy |
16,941
+1,499
| +10% | +$460K | 0.03% | 540 |
|
|
2021
Q1 | $4.92M | Buy |
15,442
+1,677
| +12% | +$537K | 0.03% | 506 |
|
|
2020
Q4 | $4.46M | Buy |
13,765
+1,065
| +8% | +$295K | 0.03% | 471 |
|
|
2020
Q3 | $3.52M | Buy |
12,700
+1,669
| +15% | +$481K | 0.03% | 456 |
|
|
2020
Q2 | $2.67M | Buy |
11,031
+1,095
| +11% | +$220K | 0.03% | 466 |
|
|
2020
Q1 | $1.44M | Sell |
9,936
-625
| -6% | -$104K | 0.02% | 547 |
|
|
2019
Q4 | $1.76M | Buy |
10,561
+2,007
| +23% | +$372K | 0.02% | 572 |
|
|
2019
Q3 | $1.52M | Sell |
8,554
-3,315
| -28% | -$717K | 0.02% | 529 |
|
|
2019
Q2 | $3.09M | Buy |
11,869
+2,397
| +25% | +$636K | 0.05% | 352 |
|
|
2019
Q1 | $2.71M | Buy |
9,472
+1,745
| +23% | +$580K | 0.06% | 327 |
|
|
2018
Q4 | $2.34M | Sell |
7,727
-1,682
| -18% | -$584K | 0.06% | 308 |
|
|
2018
Q3 | $4.23M | Buy |
9,409
+3,067
| +48% | +$1.21M | 0.09% | 221 |
|
|
2018
Q2 | $2.59M | Buy |
6,342
+5,430
| +595% | +$1.97M | 0.06% | 324 |
|
|
2018
Q1 | $265K | Sell |
912
-32
| -3% | -$8.11K | 0.01% | 738 |
|
|
2017
Q4 | $185K | Sell |
944
-26
| -3% | -$4.85K | ﹤0.01% | 753 |
|
|
2017
Q3 | $164K | Sell |
970
-44
| -4% | -$6.65K | ﹤0.01% | 757 |
|
|
2017
Q2 | $145K | Sell |
1,014
-58
| -5% | -$7.79K | ﹤0.01% | 769 |
|
|
2017
Q1 | $134K | Sell |
1,072
-100
| -9% | -$11.6K | ﹤0.01% | 764 |
|
|
2016
Q4 | $132K | Sell |
1,172
-33
| -3% | -$3.82K | ﹤0.01% | 768 |
|
|
2016
Q3 | $155K | Sell |
1,205
-38
| -3% | -$4.55K | ﹤0.01% | 749 |
|
|
2016
Q2 | $136K | Buy |
1,243
+278
| +29% | +$27.7K | ﹤0.01% | 755 |
|
|
2016
Q1 | $91K | Buy |
965
+39
| +4% | +$3.29K | ﹤0.01% | 777 |
|
|
2015
Q4 | $84K | Buy |
+926
| New | +$78.6K | ﹤0.01% | 781 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Mitsubishi UFJ Asset Management's ABMD Position: Q4 2022 in Review
Mitsubishi UFJ Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 28,070 shares — an estimated $6.9M sold.
Mitsubishi UFJ Asset Management first reported a position in ABMD in Q4 2015 and held it in 28 quarters. The position peaked at $8.21M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Mitsubishi UFJ Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Mitsubishi UFJ Asset Management sold 28,070 Abiomed Inc shares in Q4 2022, an estimated $6.9M.
- Mitsubishi UFJ Asset Management first reported a position in Abiomed Inc in Q4 2015 and held it in 28 quarters.
- Mitsubishi UFJ Asset Management's Abiomed Inc position peaked at $8.21M in Q1 2022.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.